Literature DB >> 3518772

Quantitation of dose and concentration-effect relationships for fenclofenac in rheumatoid arthritis.

F M Dunagan, P E McGill, A W Kelman, B Whiting.   

Abstract

Response to non-steroidal anti-inflammatory drugs (NSAIDs) is not usually assessed on the basis of concentration measurements: identification of a concentration-effect relationship has proved difficult to achieve. Dose and concentration-effect relationships of fenclofenac have been determined in a group of 18 patients with rheumatoid arthritis at three dose levels (600, 1200 and 1800 mg day-1). The study was double-blind and treatments were randomised according to a Latin square design. A multiple linear regression technique (GLIM) was used in the analysis. The best model to describe the change in effect in terms of dose and concentration incorporated an average slope and an individual subject intercept for each effect measurement. On average, an improvement in grip strength of 20 mm Hg could be obtained with an increase in fenclofenac (trough) concentration of 100 micrograms ml-1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518772      PMCID: PMC1400933          DOI: 10.1111/j.1365-2125.1986.tb05215.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

2.  Pharmacokinetics and biochemical effects in responders and non-responders to non-steroidal anti-inflammatory drugs.

Authors:  M Orme; N Baber; J Keenan; L Halliday; R Sibeon; T Littler
Journal:  Scand J Rheumatol Suppl       Date:  1981

3.  Four new anti-inflammatory drugs: responses and variations.

Authors:  E C Huskisson; D L Woolf; H W Balme; J Scott; S Franklin
Journal:  Br Med J       Date:  1976-05-01

Review 4.  Benoxaprofen and its effect on serum alkaline phosphatase: a review.

Authors:  R W Jones
Journal:  Eur J Rheumatol Inflamm       Date:  1982

5.  HPLC-determination of some antiinflammatory, weak analgesic and uricosuric drugs in human blood plasma and its application to pharmacokinetics.

Authors:  F Nielsen-Kudsk
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-10

6.  Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.

Authors:  P M Brooks; J J Walker; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

7.  Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis.

Authors:  M Orme; P J Holt; G R Hughes; C J Bulpitt; G H Draffan; S S Thorgeirsson; F Williams; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

8.  Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis.

Authors:  R O Day; D E Furst; S H Dromgoole; B Kamm; R Roe; H E Paulus
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875

9.  Double-blind dose-response study of indomethacin in rheumatoid arthritis.

Authors:  R Ekstrand; G Alván; M L'e Orme; R Lewander; L Palmér; B Sarby
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

10.  Variations in responses to non-steroidal anti-inflammatory drugs.

Authors:  D L Scott; S Roden; T Marshall; M J Kendall
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

View more
  8 in total

Review 1.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Variations in response to non-steroidal anti-inflammatory drugs.

Authors:  R O Day; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 3.  Variability in response to NSAIDs. Fact or fiction?

Authors:  R O Day; G G Graham; K M Williams; P M Brooks
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

4.  Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis.

Authors:  S J Preston; M H Arnold; E M Beller; P M Brooks; W W Buchanan
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

5.  The effect of concurrent aspirin upon plasma concentrations of tenoxicam.

Authors:  R O Day; P D Paull; S Lam; B R Swanson; K M Williams; D N Wade
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

6.  Clinical response to non-steroidal anti-inflammatory drugs in urate-crystal induced inflammation: a simultaneous study of intersubject and intrasubject variability.

Authors:  J S Walker; T V Nguyen; R O Day
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

7.  Variability in response to nonsteroidal anti-inflammatory analgesics: evidence from controlled clinical therapeutic trial of flurbiprofen in rheumatoid arthritis.

Authors:  S J Preston; M H Arnold; E M Beller; P M Brooks; W W Buchanan
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 8.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.